Helius Medical Technologies, INC Form 4 insider transactions

Director Sherrie L Perkins receives stock options from Helius Medical Technologies, Inc.

Director Blane Walter received stock options for 31,000 shares of Helius Medical Technologies, Inc. (HSDT) on July 2, 2024, vesting quarterly starting September 30, 2024.

Jeffrey S. Mathiesen, CFO and Treasurer of Helius Medical Technologies, received stock options for 404,000 shares under the company's 2022 Equity Incentive Plan.

Director Paul Buckman received stock options for 31,000 shares of Helius Medical Technologies, Inc. (HSDT) on July 2, 2024.

Director Edward M. Straw was granted a stock option to purchase 31,000 shares of Helius Medical Technologies, Inc. (HSDT) Class A Common Stock.

Dane Andreeff, CEO of Helius Medical Technologies, was granted stock options for 808,000 shares under the company's 2022 Equity Incentive Plan.